CNBC's Jim Cramer walked investors through next week on Wall Street, pinpointing the latest consumer price index report and a ...

Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more ...

The state attorney general's office credited the broad response to the opioid crisis, including prevention, recovery and ...

Citius Oncology (CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (CTXR), has entered into a distribution services agreement with Cardinal Health (CAH).

Fintel reports that on June 3, 2025, Wells Fargo upgraded their outlook for Cardinal Health (NYSE:CAH) from Equal-Weight to ...

UnitedHealth Group (NYSE:UNH) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high.

Citius Pharmaceuticals Inc (NASDAQ: CTXR ), the parent company of Citius Oncology, also saw its shares climb by 6.7%. Meanwhile, Cardinal Health’s stock remained flat after the news.

Cardinal Health (CAH) stock and Cencora (COR) stock were upgraded to Overweight at Wells Fargo on strong industry outlook. Read more here.

Cardinal Health’s James Roof, director of strategic distribution services, and Diana Castillo, national consignment executive ...

On Wednesday, Cardinal Health Inc. (NYSE: CAH) announced the US launch of its new Kendall DL Multi System. This ...

On June 3, Wells Fargo analysts upgraded Cardinal Health, Inc. (NYSE: CAH )’s stock to “Overweight” from “Equal Weight,” ...